DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Print   Email 

VeriChip Receives Exclusive License to RECEPTORS LLC's Patents to Use in Conjunction with its Patent No. 7,125,382 for an "Embedded Bio-Sensor System" to Develop In Vivo Glucose-Sensing RFID Microchip


10/7/2009 9:09:34 AM

DELRAY BEACH, Fla. & CHASKA, Minn.--(BUSINESS WIRE)--VeriChip Corporation ("VeriChip") (NASDAQ:CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip has received an exclusive license to RECEPTORS' Patent No. 7,504,364 titled "Methods of Making Arrays and Artificial Receptors" and Patent No. 7,469,076 "Sensors Employing Combinatorial Artificial Receptors," to use in conjunction with VeriChip's Patent No. 7,125,382 entitled "Embedded Bio-Sensor System," to develop an in vivo glucose-sensing RFID microchip.

Read at BioSpace.com

 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES